RecruitingNot ApplicableNCT05941299

Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by Lumpectomy

A Pivotal Study of REGENERA Implant in Malignant Breast Lesion Treated by Lumpectomy


Sponsor

Tensive SRL

Enrollment

92 participants

Start Date

Sep 29, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goals of this clinical trial are: * demonstrate the safety of REGENERA breast implant in patients undergoing lumpectomy of malignant breast lesions * demonstrate the safety and performance of REGENERA in terms of investigator's satisfaction, potential interference with current standard-of-care imaging techniques and occurrence of device-related serious adverse events.


Eligibility

Sex: FEMALEMin Age: 40 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating a new breast implant called REGENERA to restore breast shape after lumpectomy (partial breast removal) for early-stage breast cancer, reducing the need for more invasive reconstruction. **You may be eligible if...** - You are a woman between 40 and 70 years old - You have been diagnosed with a single or multi-focal malignant breast lesion (cancer) in one breast only, without microcalcifications - Your tumor is contained within an area no larger than 4 cm - Your cancer has not spread to other organs (non-metastatic, M0) - You are scheduled for lumpectomy **You may NOT be eligible if...** - Your cancer has spread to other parts of the body - You have cancer in both breasts - You require a full mastectomy - You have had prior breast implants or extensive breast surgery - You have conditions that impair wound healing Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEREGENERA breast implant implantation

Each patient will perform 13 study visits, and at each visit, all necessary study procedures will be performed according to the clinical investigation plan: * Screening * Pre-surgery treatment * Surgery and study device implant * Post-surgery follow-up


Locations(3)

IEO Istituto Europeo di Oncologia

Milan, Italy

A.O.U. Pisana - Ospedale Santa Chiara

Pisa, Italy

Complejo Hospitalario Universitario A Coruña

A Coruña, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05941299


Related Trials